General Information of Drug (ID: DMEC1I9)

Drug Name
Zn2+ Drug Info
Synonyms
zinc ion; Zinc cation; zinc(2+); Zinc, ion (Zn2+); 23713-49-7; Zn(II); Velmanase Alfa; UNII-13S1S8SF37; Zinc (II) ion; zinc(2+) ion; Zinc (II); Velmanase Alfa [INN]; Zn+2; CHEBI:29105; Zn(2+); 13S1S8SF37; 9025-42-7; Microheterogeneityzinc Ion; alpha-Mannanase; Zinc ions; alpha-Mannosidase; Zinc(2+)ions; Mannosidase, alpha-; alpha-Mannopyranosidase; Zinc 2+; Rhlaman; dietary zinc; UNII-M91TG242P2; Zinc dication; zinc(II) cation; Zinc divalent ion; alpha-Mannosidase recombinant human; Recombinant Human Alpha-mannosidase
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
32051
ChEBI ID
CHEBI:29105
CAS Number
CAS 23713-49-7
TTD Drug ID
DMEC1I9

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Myo-inositol DMQKSGI Alzheimer disease 8A20 Phase 2 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mycobacterium CDP-diacylglycerol-inositol phosphatidyltransferase (MycB pssA) TTI0TCK PSS_MYCTU Inhibitor [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 566).
2 Phosphatidylinositol synthesis in mycobacteria. Biochim Biophys Acta. 1999 Jan 4;1436(3):437-50.